Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC Meeting Abstract
| Authors: | Garassino, M. C. C.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E. F. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Thomas, M.; Viteri, S.; Iams, W. T.; Kim, H. R.; Yang, J.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. K. |
| Abstract Title: | Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S984 |
| End Page: | S985 |
| Language: | English |
| ACCESSION: | WOS:000700527702270 |
| DOI: | 10.1016/j.annonc.2021.08.1857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1254P -- Source: Wos |
